Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27471022 | 0.78 | LMNA (0.56) | LMNATHRB | |
| SCHEMBL28099090 | 0.78 | LMNA (0.43) | LMNATHRB | |
| SCHEMBL7260913 | 0.71 | — | — | |
| SCHEMBL9546948 | 0.70 | LMNA (0.42) | LMNATHRB | |
| SCHEMBL12514138 | 0.69 | LMNA (0.45) | LMNATHRB | |
| SCHEMBL309862 | 0.67 | — | — | |
| SCHEMBL29012739 | 0.67 | LMNA (0.50) | LMNATHRB | |
| SCHEMBL20886292 | 0.67 | LMNA (0.50) | LMNATHRB | |
| SCHEMBL29012741 | 0.67 | LMNA (0.50) | LMNATHRB | |
| SCHEMBL27803885 | 0.67 | THRB (0.44) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438038-B1 | PROCESS FOR THE PREPARATION OF SECONDARY OR TERTIARY AMINES | HUNTSMAN CORP HUNGARY ZRT (HU) | 2016-04-20 | — | — | EP | disclosed |
| US-8822729-B2 | Method for providing a secondary or tertiary amine | HUNTSMAN INTERNATIONAL LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | Huntsman Corporation Hungary ZRt (HU) | 2014-06-05 | — | — | US | disclosed |
| US-8664445-B2 | Method for providing a secondary or tertiary amine | HUNTSMAN INTERNATIONAL LLC (US) | 2014-03-04 | — | — | US | disclosed |
| US-8658831-B2 | Method for separating N,N-dialkylbisaminoalkylether from mixtures comprising N,N-dialkylbisaminoalkylbisaminoalkylether and at least one of N,N,N′-trialkylbisaminoalkylether and N,N,N′,N′-tetraalkylbisaminoalkylether | HUNTSMAN INTERNATIONAL LLC (US) | 2014-02-25 | — | — | US | disclosed |
| EP-2438039-B1 | A METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN CORP HUNGARY ZRT (HU) | 2013-07-31 | — | — | EP | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| EP-2438038-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | Huntsman Corporation Hungary ZRt. (HU) | 2012-04-11 | — | — | EP | disclosed |
| EP-2438039-A1 | A METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | Huntsman Corporation Hungary ZRt. (HU) | 2012-04-11 | — | — | EP | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| WO-2010139520-A1 | A Method for Separating N,N-Dialkylbisaminoalkylether from Mixtures Comprising N,N-Dialkylbisaminoalkylether and at least one of N,N,N'-Trialkylbisaminoalkylether and N,N,N',N'-Tetraalkylbisaminoalkylether | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | HRH3, HRH4, NPR3 | LMNA 2889/4885THRB 129/4885 |
| US-20140155655-A1 | Method for providing a secondary or tertiary amine | HRH3, HRH4, GLRA3 | LMNA 3369/4885THRB 125/4885 |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | NCLN, NCL, DNPH1 | LMNA 84/4885THRB 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.